News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

MacroGenics, Inc. (MGNX) To Present At The 26th Annual ROTH Conference



3/4/2014 9:33:34 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

ROCKVILLE, Md., March 3, 2014 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq:MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of cancer and autoimmune diseases, today announced that Jon Wigginton, M.D., Senior Vice President, Clinical Development and Jim Karrels, Vice President and Chief Financial Officer, of MacroGenics, are scheduled to present at the 26th Annual ROTH Conference on Monday, March 10, at 10:30 a.m. Pacific (1:30 p.m. Eastern Time).

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES